STOCK TITAN

Champions Oncology, Inc. (CSBR) Revenue by Year

CSBR

Champions Oncology, Inc. generated $59.4M in revenue in fiscal year 2026. This represents an increase of 4.4% from the prior fiscal year. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to $60.7M in revenue. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Champions Oncology, Inc. has filed alongside them.

FY2026 annual
Revenue $59.4M
YoY +4.4%
5Y CAGR +7.7%
10Y CAGR +18.2%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jul 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CSBR Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2610-KFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Revenue$60.7M$59.4M+4.4%$56.9M+13.5%$50.2M-6.9%$53.9M+9.7%$49.1M+19.7%$41.0M+27.8%$32.1M+18.7%$27.1M+33.7%$20.2M+31.3%$15.4M+37.8%$11.2M+26.2%$8.9M-23.3%$11.6M+38.8%$8.3M+16.4%$7.1M

TTM is the trailing twelve months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

CSBR Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Revenue$15.2M+8.8%$13.8M+12.0%$16.6M-2.8%$15.0M+11.5%$14.0M-0.5%$12.4M-11.8%$17.0M+41.8%$13.5M+16.6%$14.1M+11.9%$14.0M+7.1%$12.0M-5.9%$11.6M-19.0%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Champions Oncology, Inc. financials

Frequently Asked Questions

What was Champions Oncology, Inc.'s revenue in fiscal year 2026?

Champions Oncology, Inc. generated $59.4M in revenue in fiscal year 2026.

How fast is Champions Oncology, Inc.'s revenue growing?

Champions Oncology, Inc. (CSBR) revenue rose by 4.4% year over year, from $56.9M to $59.4M in fiscal year 2026.

What is Champions Oncology, Inc.'s revenue over the last twelve months?

Champions Oncology, Inc. (CSBR) reported $60.7M in revenue over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Champions Oncology, Inc. (CSBR) revenue went from $7.1M in fiscal year 2012 to $59.4M in fiscal year 2026.

Champions Oncology, Inc. (CSBR) reported $15.2M in revenue in Q1 2027. This represents an increase of 8.8% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Champions Oncology, Inc. (CSBR) reported on that line in every period on record.